PHM7 Stock Overview
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 6/6 |
Altria Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$37.25 |
52 Week High | US$42.24 |
52 Week Low | US$36.75 |
Beta | 0.70 |
1 Month Change | 0% |
3 Month Change | 0.57% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -5.56% |
Recent News & Updates
Recent updates
Shareholder Returns
PHM7 | BG Tobacco | BG Market | |
---|---|---|---|
7D | 0% | 1.0% | 0.2% |
1Y | n/a | -17.6% | 17.0% |
Return vs Industry: Insufficient data to determine how PHM7 performed against the BG Tobacco industry.
Return vs Market: Insufficient data to determine how PHM7 performed against the BG Market.
Price Volatility
PHM7 volatility | |
---|---|
PHM7 Average Weekly Movement | n/a |
Tobacco Industry Average Movement | 2.8% |
Market Average Movement | 4.1% |
10% most volatile stocks in BG Market | 8.5% |
10% least volatile stocks in BG Market | 2.4% |
Stable Share Price: PHM7 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHM7's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
PHM7 fundamental statistics | |
---|---|
Market cap | €69.69b |
Earnings (TTM) | €7.88b |
Revenue (TTM) | €18.97b |
8.8x
P/E Ratio3.7x
P/S RatioIs PHM7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHM7 income statement (TTM) | |
---|---|
Revenue | US$20.36b |
Cost of Revenue | US$6.15b |
Gross Profit | US$14.21b |
Other Expenses | US$5.75b |
Earnings | US$8.46b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
Earnings per share (EPS) | 4.92 |
Gross Margin | 69.78% |
Net Profit Margin | 41.53% |
Debt/Equity Ratio | -494.5% |
How did PHM7 perform over the long term?
See historical performance and comparison